STAT+: U.K. unveils recommendations for regulating AI in medicine
A U.K. commission has unveiled its recommendations for how the country should regulate artificial intelligence in medicine.
London — The U.K. commission announced its suggestions on Thursday for regulating artificial intelligence (AI) in the medical field, as health organizations worldwide grapple with how to consistently monitor evolving products post-authorization, rather than merely obtaining initial market clearance. The report aimed to strike a balance between capitalizing on AI's potential in medicine, such as utilizing it to examine the vast number of annual scans for tracking eye health in diabetic patients, while emphasizing safety, long-term performance tracking, and equitable patient treatment.
The 44 recommendations encompass measures to enable phased approval of new AI models and establish a reporting system for healthcare providers to document tool performance in their clinics, including instances of malfunction or potential interference with patient care as these models evolve and adapt, yielding varying results based on the specific setting.
Written by urgent.news from STAT News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
